These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 31129574)

  • 1. Mapping the study topics and characteristics of HIV pre-exposure prophylaxis research literature: a protocol for a scoping review.
    Kamitani E; Johnson AH; Wichser M; Mizuno Y; DeLuca JB; Higa DH
    BMJ Open; 2019 May; 9(5):e024212. PubMed ID: 31129574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping the Study Characteristics and Topics of HIV Pre-Exposure Prophylaxis Research Literature: A Scoping Review.
    Kamitani E; Mizuno Y; Wichser M; Adegbite AH; DeLuca JB; Higa DH
    AIDS Educ Prev; 2019 Dec; 31(6):505-522. PubMed ID: 31815530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation of HIV pre-exposure prophylaxis strategies: protocol for a methodological systematic review and quantitative synthesis.
    Thavorn K; Kugathasan H; Tan DHS; Moqueet N; Baral SD; Skidmore B; MacFadden D; Simkin A; Mishra S
    Syst Rev; 2018 Mar; 7(1):47. PubMed ID: 29544530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE.
    Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I;
    BMJ Open; 2016 Jun; 6(6):e012179. PubMed ID: 27324719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PrEP Implementation for Mothers in Antenatal Care (PrIMA): study protocol of a cluster randomised trial.
    Dettinger JC; Kinuthia J; Pintye J; Mwongeli N; Gómez L; Richardson BA; Barnabas R; Wagner AD; O'Malley G; Baeten JM; John-Stewart G
    BMJ Open; 2019 Mar; 9(3):e025122. PubMed ID: 30850409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current landscape of pre-exposure prophylaxis service delivery models for HIV prevention: a scoping review.
    Vanhamel J; Rotsaert A; Reyniers T; Nöstlinger C; Laga M; Van Landeghem E; Vuylsteke B
    BMC Health Serv Res; 2020 Jul; 20(1):704. PubMed ID: 32736626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing preferences for HIV pre-exposure prophylaxis (PrEP) delivery services via online pharmacies in Kenya: protocol for a discrete choice experiment.
    Chen Y; Saldarriaga EM; Montano MA; Ngure K; Thuo N; Kiptinness C; Rafferty M; Terris-Prestholt F; Stergachis A; Mugambi ML; Ortblad KF; Sharma M
    BMJ Open; 2023 Apr; 13(4):e069195. PubMed ID: 37012008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal pre-exposure prophylaxis (PrEP) acceptability, initiation and adherence among criminal justice-involved adults in the USA: the Southern PrEP Cohort Study (SPECS) protocol.
    LeMasters K; Oser C; Cowell M; Mollan K; Nowotny K; Brinkley-Rubinstein L
    BMJ Open; 2021 Jul; 11(7):e047340. PubMed ID: 34272219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-exposure and postexposure prophylaxes and the combination HIV prevention methods (The Combine! Study): protocol for a pragmatic clinical trial at public healthcare clinics in Brazil.
    Grangeiro A; Couto MT; Peres MF; Luiz O; Zucchi EM; de Castilho EA; Estevam DL; Alencar R; Wolffenbüttel K; Escuder MM; Calazans G; Ferraz D; Arruda É; Corrêa Mda G; Amaral FR; Santos JC; Alvarez VS; Kietzmann T
    BMJ Open; 2015 Aug; 5(8):e009021. PubMed ID: 26307622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns.
    Tetteh RA; Yankey BA; Nartey ET; Lartey M; Leufkens HG; Dodoo AN
    Drug Saf; 2017 Apr; 40(4):273-283. PubMed ID: 28130774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact, cost and cost-effectiveness of oral pre-exposure prophylaxis in sub-Saharan Africa: a scoping review of modelling contributions and way forward.
    Case KK; Gomez GB; Hallett TB
    J Int AIDS Soc; 2019 Sep; 22(9):e25390. PubMed ID: 31538407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review of Telehealth Innovations for HIV Pre-Exposure Prophylaxis (PrEP).
    Touger R; Wood BR
    Curr HIV/AIDS Rep; 2019 Feb; 16(1):113-119. PubMed ID: 30701404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equity considerations in outcome measures of the HIV pre-exposure prophylaxis care continuum in high-income countries: a systematic review protocol.
    Cabecinha M; Solomon D; Rait G; Saunders J; Mohammed H; McDonagh LK
    BMJ Open; 2021 Feb; 11(2):e040701. PubMed ID: 33542038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low- and middle-income countries: a systematic review and meta-analysis.
    Yi S; Tuot S; Mwai GW; Ngin C; Chhim K; Pal K; Igbinedion E; Holland P; Choub SC; Mburu G
    J Int AIDS Soc; 2017 Jun; 20(1):21580. PubMed ID: 28691439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexually transmitted infections among high-risk populations that use treatment as prevention or pre-exposure prophylaxis: a protocol for a systematic review.
    Coudray M; Kiplagat S; Saumell F; Madhivanan P
    BMJ Open; 2019 Dec; 9(12):e032054. PubMed ID: 31811008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PrEP implementation: moving from trials to policy and practice.
    Cáceres CF; O'Reilly KR; Mayer KH; Baggaley R
    J Int AIDS Soc; 2015; 18(4 Suppl 3):20222. PubMed ID: 26198349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pharmacist's Expanding Role in HIV Pre-Exposure Prophylaxis.
    Farmer EK; Koren DE; Cha A; Grossman K; Cates DW
    AIDS Patient Care STDS; 2019 May; 33(5):207-213. PubMed ID: 31067124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long acting systemic HIV pre-exposure prophylaxis: an examination of the field.
    Lykins WR; Luecke E; Johengen D; van der Straten A; Desai TA
    Drug Deliv Transl Res; 2017 Dec; 7(6):805-816. PubMed ID: 28612340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection.
    Özdener AE; Park TE; Kalabalik J; Gupta R
    Expert Rev Anti Infect Ther; 2017 May; 15(5):467-481. PubMed ID: 28322067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.